mRNA-1273: Maganin Coronavirus yana shirye don gwajin asibiti:
 
Maganin Coronavirus yana shirye don gwajin asibiti
Kamfanin Kamfanin kere-kere na Moderna, daga Cambridge, Mass., Ya ba da sanarwar cewa allurar rigakafinsa, mRNA-1273, don kwayar cutar Covid-19 da ke yaduwa da sauri za ta shiga gwajin asibiti na Farko 1 a Amurka. An riga an aika da rukunin farko na sabon rigakafin ga Kwalejin Allergy da Cututtuka na (NIAID).
mRNA-1273 ta Moderna ta haɗu tare da haɗin gwiwar masu bincike daga Cibiyar Bincike na NIAID Vacccine (VCR). An bayar da kuɗin samar da ayyukan ne ta hanyar alungiyoyin Ba da Agaji Kan Cutar Cutar Kananan Yara (CEPI). Nazarin aminci da rigakafi, wanda zai fara daga ranar 6 ga Maris, zai hada da maza da mata masu lafiya 45 masu shekaru 18-55. Masu halarta zasu sami maganin a allurai 25, 100 ko 250 microgram (ƙarin game da binciken anan). Anthony Fauci, darektan NIAID, ya ce a cikin wata sanarwa da jaridar The Wall Street Journal ta ce za a fara gudanar da binciken ne kafin karshen watan Afrilu. Koyaya, zai ɗauki daga wata zuwa watanni 18 kafin allurar ta fara amfani dashi gabaɗaya.
Juan Andres, Babban Jami'in Harkokin Fasaha da Darakta mai inganci a Moderna, sharhi - Ina son in gode wa daukacin kungiyar Moderna saboda kokarinsu na ban mamaki, wanda hakan martani ne ga matsalar lafiyar duniya. Haɗin kai tare da NIAID da CEPI sun ba da damar samar da rukunin asibiti a cikin kwanaki 42 na tantance mai zuwa. A cewar tashar yanar gizo ta axios.com, idan halin da ake ciki a kasar Sin ya kara tabarbarewa, to akwai hadarin karancin magunguna ga kasar Amurka kusan magunguna 150 (wadanda suka hada da maganin rigakafi, kwayoyin halitta, magungunan da ba su maye gurbinsu ba). A cewar tashar, an sanya wadannan magungunan a jerin hadarin a Hukumar Kula da Abinci da Magunguna ta Amurka (FDA). Kodayake FDA ba ta yi sharhi ba game da waɗannan rahotannin, yana jaddada cewa ƙarin yaduwar cutar coronavirus na iya shafar sarkar samar da kayayyaki.
Matsakaicin halin yanzu na coronavirus na duniya ya wuce dubu 79. kamuwa da cuta, sama da 2.6 dubu mutuwar mutane, masu rinjaye a China. An kuma tabbatar da barkewar annobar a Italiya, Koriya ta Kudu da Iran. Maganin rigakafin sabuwar nau'in coronavirus, tare da haɗin gwiwar gwamnatin Amurka, shima yana aiki, da sauransu Johnson & Johnson, Regeneron Pharmaceuticals da Sanofi.